Cargando…
Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
[Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376956/ https://www.ncbi.nlm.nih.gov/pubmed/35912476 http://dx.doi.org/10.1021/acs.jmedchem.1c02206 |
_version_ | 1784768243117850624 |
---|---|
author | Gehrtz, Paul Marom, Shir Bührmann, Mike Hardick, Julia Kleinbölting, Silke Shraga, Amit Dubiella, Christian Gabizon, Ronen Wiese, Jan N. Müller, Matthias P. Cohen, Galit Babaev, Ilana Shurrush, Khriesto Avram, Liat Resnick, Efrat Barr, Haim Rauh, Daniel London, Nir |
author_facet | Gehrtz, Paul Marom, Shir Bührmann, Mike Hardick, Julia Kleinbölting, Silke Shraga, Amit Dubiella, Christian Gabizon, Ronen Wiese, Jan N. Müller, Matthias P. Cohen, Galit Babaev, Ilana Shurrush, Khriesto Avram, Liat Resnick, Efrat Barr, Haim Rauh, Daniel London, Nir |
author_sort | Gehrtz, Paul |
collection | PubMed |
description | [Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography–mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter. |
format | Online Article Text |
id | pubmed-9376956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93769562022-08-16 Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries Gehrtz, Paul Marom, Shir Bührmann, Mike Hardick, Julia Kleinbölting, Silke Shraga, Amit Dubiella, Christian Gabizon, Ronen Wiese, Jan N. Müller, Matthias P. Cohen, Galit Babaev, Ilana Shurrush, Khriesto Avram, Liat Resnick, Efrat Barr, Haim Rauh, Daniel London, Nir J Med Chem [Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography–mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter. American Chemical Society 2022-07-30 2022-08-11 /pmc/articles/PMC9376956/ /pubmed/35912476 http://dx.doi.org/10.1021/acs.jmedchem.1c02206 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Gehrtz, Paul Marom, Shir Bührmann, Mike Hardick, Julia Kleinbölting, Silke Shraga, Amit Dubiella, Christian Gabizon, Ronen Wiese, Jan N. Müller, Matthias P. Cohen, Galit Babaev, Ilana Shurrush, Khriesto Avram, Liat Resnick, Efrat Barr, Haim Rauh, Daniel London, Nir Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries |
title | Optimization
of Covalent MKK7 Inhibitors via Crude Nanomole-Scale
Libraries |
title_full | Optimization
of Covalent MKK7 Inhibitors via Crude Nanomole-Scale
Libraries |
title_fullStr | Optimization
of Covalent MKK7 Inhibitors via Crude Nanomole-Scale
Libraries |
title_full_unstemmed | Optimization
of Covalent MKK7 Inhibitors via Crude Nanomole-Scale
Libraries |
title_short | Optimization
of Covalent MKK7 Inhibitors via Crude Nanomole-Scale
Libraries |
title_sort | optimization
of covalent mkk7 inhibitors via crude nanomole-scale
libraries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376956/ https://www.ncbi.nlm.nih.gov/pubmed/35912476 http://dx.doi.org/10.1021/acs.jmedchem.1c02206 |
work_keys_str_mv | AT gehrtzpaul optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT maromshir optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT buhrmannmike optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT hardickjulia optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT kleinboltingsilke optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT shragaamit optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT dubiellachristian optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT gabizonronen optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT wiesejann optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT mullermatthiasp optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT cohengalit optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT babaevilana optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT shurrushkhriesto optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT avramliat optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT resnickefrat optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT barrhaim optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT rauhdaniel optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries AT londonnir optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries |